Hubertus von BaumbachChairman of the Board of Managing Directors |
Law degree and second state exam, MBA Professional milestones 2012 – 2016 Member of the Board of Managing Directors with responsibility for Finance, Boehringer Ingelheim 2009 – 2012 Member of the Board of Managing Directors with responsibility for Finance and Animal Health, Boehringer Ingelheim 2006 – 2008 Vice President Finance, Boehringer Ingelheim Deutschland 2003 – 2005 Head of department Controlling Subsidiaries, Boehringer Ingelheim 2002 – 2003 Head of group Controlling CHC, Boehringer Ingelheim Since 2001 Employee of Boehringer Ingelheim |
Carinne BrouillonMember of the Board of Managing Directors with responsibility for the Human Pharma Business Unit |
*5 June 1965 Professional milestones 2018 – 2019 Global Head of Therapeutic Areas, Boehringer Ingelheim 2014 – 2018 Head of Global Commercial Strategy Neuroscience at Janssen, Johnson & Johnson’s Pharmaceutical Company 2012 – 2018 President of Janssen Therapeutics and Member of the Janssen North America Leadership Team 1997 – 2012 Various positions in sales, marketing and general management at Johnson & Johnson, EMEA (Europe, Middle East, Africa) |
Dr Michel PairetMember of the Board of Managing Directors with responsibility for the Innovation Unit |
*17 June 1959 Professional milestones 2012 – 2015 Corporate Senior Vice President Global Research and non-clinical Development, Boehringer Ingelheim 2010 – 2012 Head of Boehringer Ingelheim Venture Fund, Boehringer Ingelheim 2007 – 2010 Corporate Senior Vice President Research, Boehringer Ingelheim 2004 – 2007 Head of Research Site Germany, Boehringer Ingelheim 1997 – 2004 Head of department Respiratory Research, Boehringer Ingelheim |
Jean Scheftsik de SzolnokMember of the Board of Managing Directors with responsibility for the Animal Health business |
*2 August 1963 Professional milestones 2017 – 2019 Country Management Director France - Boehringer Ingelheim 2016 – 2017 Corporate Senior Vice President Human Pharma Regions - Boehringer Ingelheim 2015 – 2016 Corporate Senior Vice President Human Pharma Japan/USA/Canada - Boehringer Ingelheim 2013 – 2015 Corporate Vice President Europe - Boehringer Ingelheim 2010 – 2013 Corporate Vice President Southern Europe – Boehringer Ingelheim 1987 – 2010 Various General Manager positions at Boehringer Ingelheim in Canada, Belgium, France, Germany |
Michael SchmelmerMember of the Board of Managing Directors with responsibility for Finance & Group Functions |
*17 June 1964 Professional milestones 2016 – today Founder and Managing Director of BI X, the digital lab of Boehringer Ingelheim 2012 – 2017 CIO, Corporate Senior Vice President Information Technology, Boehringer Ingelheim 2006 – 2012 Corporate Vice President IT & CIO, Infineon AG 2003 – 2006 Vice President IT Business Transformation, Infineon AG 2000 – 2003 Vice President Logistics & Supply Chain Management IT Systems, Infineon AG 1999 – 2000 Senior Director of Supply Chain Management Competence Center IT, Infineon AG |
Shashank DeshpandeMember of the Board of Managing Directors |
*1 April 1973 Professional milestones 2022 - 2023 Country Managing Director, Japan 2020 - 2022 Head of Human Pharma, Japan 2019 - 2020 Head of Specialty Care, Japan 2017 - 2019 Head of Marketing, Japan 2014 - 2017 Head of Diabetes Marketing, Japan 2012 - 2014 Global Brand Team Leader Trajenta® (Ingelheim, Germany) 2002 - 2012 Various roles in US and Global Marketing at Sanofi, US 1999 - 2002 Strategy consultant at Cap Gemini, Germany |
Dr Paola CasarosaMember of the Board of Managing Directors |
*2 February 1974 Professional milestones 2020 – 2023 Global Head of Therapeutic Areas 2019 - 2020 Global Therapeutic Area Head CNS, Retinopathy and Emerging areas 2019 - Head of Research Site Biberach, Germany 2014 - 2018 Global Head of Business Development, Prescription Medicine 2013 - 2014 Head of Therapeutic Alliances and Strategic Partnerships 2010 - 2013 Global Head Business Development and Licensing for Respiratory 2004 - 2010 Various Research roles at Boehringer Ingelheim and Organon (MSD) |
Conselho de Administração
A Boehringer Ingelheim é uma empresa familiar gerida por um Conselho de Administração.
